Georgetown University Medical Center, Department of Microbiology and Immunology, 3900 Reservoir Rd., N.W., Med-Dent Building, RM SW319, Washington, DC 20057, USA.
Virology. 2013 Mar 30;438(1):20-7. doi: 10.1016/j.virol.2013.01.006. Epub 2013 Feb 9.
A highly active, fluorescence-based, in vitro assay for human Norovirus protease from genogroup I and II viruses was optimized utilizing as little as 0.25μM enzyme, pH 7.6, and substrate:enzyme of 50-100. Activity in Tris-HCl or sodium phosphate buffers was 2-fold less than HEPES, and 2-fold lower for buffer concentrations over 10mM. Protease activity at pH 7.6 was 73% (GI) or 63% (GII) of activity at the optimal pH 9.0. Sodium inhibited activity 2-3 fold, while potassium, calcium, magnesium, and manganese inhibited 5-10 fold. Differences in efficiency due to pH, buffer, and cations were due to changes in kcat and not Km. Norovirus protease bound short RNAs representing the 3' or 5' ends of the virus, inhibiting protease activity (IC50 3-5μM) in a non-competitive manner. Previous reports indicated participation of the protease in the Norovirus replicase complex. The current studies provide initial support for a defined role for the viral protease in Norovirus replication.
一种基于荧光的高度活跃的体外人类诺如病毒蛋白酶检测方法,针对 I 型和 II 型病毒进行了优化,其酶用量低至 0.25μM,pH 值为 7.6,底物与酶的比例为 50-100。在 Tris-HCl 或磷酸钠缓冲液中的活性比 HEPES 低 2 倍,缓冲液浓度超过 10mM 时活性低 2 倍。在 pH 7.6 时,GI 型的蛋白酶活性为最佳 pH 9.0 时的 73%,GII 型为 63%。钠离子抑制活性 2-3 倍,而钾、钙、镁和锰则抑制 5-10 倍。由于 pH 值、缓冲液和阳离子导致的效率差异是由于 kcat 的变化而不是 Km。诺如病毒蛋白酶结合了代表病毒 3'或 5'末端的短 RNA,以非竞争性方式抑制蛋白酶活性(IC50 为 3-5μM)。先前的报告表明蛋白酶参与了诺如病毒复制酶复合物。目前的研究为病毒蛋白酶在诺如病毒复制中的明确作用提供了初步支持。